Despite a 94% historical correlation, ADP and BLS job reports often diverge due to differing methodologies. Read more here.
Amid countless resumes and interviews, identifying individuals with the right mix of cognitive ability and communication ...
Far-from-equilibrium dynamics controls a broad range of processes in nature and technology, from celestial events to atoms.
Sixty years ago, the Met Office embarked on a journey that would transform weather forecasting in the United Kingdom and ...
Revenues for the second quarter of fiscal 2025 were $65.9 million compared with $54.5 million for the same period of fiscal 2024. The year-over-year increase was driven by organic growth and the ...
MedPage Today on MSN
Selution's 1-Year Data Push Drug-Coated Balloons Further Into the Mainstream
SAN FRANCISCO -- The investigational Selution drug-coated balloon (DCB or DEB) edged closer to primetime in percutaneous ...
Stocktwits on MSN
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback
The Phase 3 ESSENCE study for Amondys 45 and Vyondys 53 failed to meet its primary endpoint, showing only modest numerical ...
Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its ...
The intersection of AI and algorithmic crypto signals is the turning point in digital finance. As markets grow, volume and ...
Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results